Literature DB >> 24105073

Glucose intolerance states in women with the polycystic ovary syndrome.

R Pasquali1, A Gambineri.   

Abstract

The polycystic ovary syndrome (PCOS), the most common hyperandrogenic disorder affecting 4-7% of women, is often associated with metabolic alterations, chiefly insulin resistance and obesity. Based on available scientific evidence, PCOS should be regarded as an independent risk for the development of glucose intolerance states. This short review summarizes the available literature on the prevalence and incidence of impaired glucose tolerance and Type 2 diabetes in this disorder. In addition, some insights on potential factors responsible for individual susceptibility are discussed. Targeted intervention studies focused on prevention and treatment of glucose intolerance states in PCOS are warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105073     DOI: 10.1007/BF03346757

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  62 in total

1.  The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

Authors:  J J Conn; H S Jacobs; G S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  2000-01       Impact factor: 3.478

2.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

3.  Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

Authors:  R J Norman; L Masters; C R Milner; J X Wang; M J Davies
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

4.  Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.

Authors:  Edmond P Wickham; Kathryn G Ewens; Richard S Legro; Andrea Dunaif; John E Nestler; Jerome F Strauss
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 6.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

7.  The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.

Authors:  N Xita; I Georgiou; L Lazaros; V Psofaki; G Kolios; A Tsatsoulis
Journal:  Hum Reprod       Date:  2008-01-11       Impact factor: 6.918

8.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

Authors:  E Dahlgren; S Johansson; G Lindstedt; F Knutsson; A Odén; P O Janson; L A Mattson; N Crona; P A Lundberg
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329

9.  Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study.

Authors:  Hamidreza Mani; Miles J Levy; Melanie J Davies; Danielle H Morris; Laura J Gray; John Bankart; Hannah Blackledge; Kamlesh Khunti; Trevor A Howlett
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-06       Impact factor: 3.478

Review 10.  Sex hormone binding globulin and insulin resistance.

Authors:  Ian R Wallace; Michelle C McKinley; Patrick M Bell; Steven J Hunter
Journal:  Clin Endocrinol (Oxf)       Date:  2013-03       Impact factor: 3.478

View more
  10 in total

1.  Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.

Authors:  M C Amato; R Vesco; E Vigneri; A Ciresi; C Giordano
Journal:  J Endocrinol Invest       Date:  2015-08-21       Impact factor: 4.256

2.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

3.  Metformin in women with PCOS, pros.

Authors:  Renato Pasquali; Pasquali Renato
Journal:  Endocrine       Date:  2014-06-10       Impact factor: 3.633

Review 4.  The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Song Yang; Yuan-Yuan Gu; Fei Jing; Chun-Xiao Yu; Qing-Bo Guan
Journal:  Med Sci Monit       Date:  2019-01-20

5.  Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome.

Authors:  Jiayu Huang; Jun Zhao; Xueying Geng; Weiwei Chu; Shang Li; Zi-Jiang Chen; Yanzhi Du
Journal:  Mol Ther Nucleic Acids       Date:  2020-12-15       Impact factor: 8.886

Review 6.  Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature.

Authors:  Yalan Xu; Jie Qiao
Journal:  J Healthc Eng       Date:  2022-03-21       Impact factor: 2.682

7.  How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.

Authors:  Xiaoxuan Zhao; Xiaoling Feng; Xinjie Zhao; Yuepeng Jiang; Xianna Li; Jingyun Niu; Xiaoyu Meng; Jing Wu; Guowang Xu; Lihui Hou; Ying Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

8.  Retinal nerve fiber layer thickness in women with polycystic ovary syndrome.

Authors:  Mehmet Demir; Dilek Guven; Arzu Koc; Savas Ozdemir; Efe Can
Journal:  J Ophthalmol       Date:  2013-11-26       Impact factor: 1.909

9.  Bone mineral density in women with polycystic ovary syndrome.

Authors:  K Katulski; S Slawek; A Czyzyk; A Podfigurna-Stopa; K Paczkowska; N Ignaszak; N Podkowa; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

Review 10.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.